PyInvesting

Market research

SLJ.F IntriCon Corporation

F EUR Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
211M
P/E ratio
Not available
Analyst target
25
Dividend yield
0.0%
Beta
1.01

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

IntriCon Corporation is currently in a long term uptrend where the price is trading 8.7% above its 200 day moving average.

From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.9.

IntriCon Corporation's total revenue rose by 9.4% to $30M since the same quarter in the previous year.

Its net income has increased by 42.4% to $1M since the same quarter in the previous year.

Finally, its free cash flow grew by 511.1% to $5M since the same quarter in the previous year.

Based on the above factors, IntriCon Corporation gets an overall score of 5/5.